ANALYTE SENSOR QUALITY MEASURES AND RELATED THERAPY ACTIONS FOR AN AUTOMATED THERAPY DELIVERY SYSTEM
Techniques disclosed herein relate to continuous analyte sensor measurements. In some embodiments, the techniques may involve determining that sensor-generated values indicative of a glucose level of a patient are or are to be inhibited when in a first mode. The techniques may further involve responsive to determining that the sensor-generated values are or are to be inhibited, switching operation of an infusion device from the first mode to a second mode. The techniques may further involve obtaining a blood glucose reading from the patient. The techniques may further involve responsive to obtaining the blood glucose reading, reverting operation of the infusion device to the first mode.
1 . A method, comprising:
determining that sensor-generated values indicative of a glucose level of a patient are or are to be inhibited when in a first mode;
responsive to determining that the sensor-generated values are or are to be inhibited, switching operation of an infusion device from the first mode to a second mode;
obtaining a blood glucose reading from the patient; and
responsive to obtaining the blood glucose reading, reverting operation of the infusion device to the first mode.
2 . The method of claim 1 , further comprising prompting the patient to provide the blood glucose reading after switching the operation of the infusion device from the first mode to the second mode.
3 . The method of claim 1 , wherein the blood glucose reading is obtained from a finger stick device.
4 . The method of claim 1 , wherein the first mode is an automatic delivery mode in which the sensor-generated values are used to calculate insulin dosages.
5 . The method of claim 4 , wherein the automatic delivery mode comprises calculation of bolus dosages of insulin.
6 . The method of claim 1 , further comprising prompting the patient to replace a continuous glucose sensor that provides the sensor-generated values and/or to check an integrity of the continuous glucose sensor.
7 . The method of claim 1 , wherein the second mode comprises providing a constant basal rate of insulin.
8 . The method of claim 1 , further comprising prompting the patient to recalibrate a glucose sensor that provides the sensor-generated values.
9 . The method of claim 1 , wherein reverting operation of the infusion device to the first mode comprises utilizing the blood glucose reading to calculate insulin dosages while operating in an automatic delivery mode.
10 . A system, comprising:
one or more processors; and
one or more processor-readable media storing instructions which, when executed by the one or more processors, cause performance of:
determining that sensor-generated values indicative of a glucose level of a patient are or are to be inhibited when in a first mode;
responsive to determining that the sensor-generated values are or are to be inhibited, switching operation of an infusion device from the first mode to a second mode;
obtaining a blood glucose reading from the patient; and
responsive to obtaining the blood glucose reading, reverting operation of the infusion device to the first mode.
11 . The system of claim 10 , wherein the instructions further cause performance of prompting the patient to provide the blood glucose reading after switching the operation of the infusion device from the first mode to the second mode.
12 . The system of claim 10 , wherein the blood glucose reading is obtained from a finger stick device.
13 . The system of claim 10 , wherein the first mode is an automatic delivery mode in which the sensor-generated values are used to calculate insulin dosages.
14 . The system of claim 13 , wherein the automatic delivery mode comprises calculation of bolus dosages of insulin.
15 . The system of claim 10 , wherein the instructions further cause performance of prompting the patient to replace a continuous glucose sensor that provides the sensor-generated values and/or to check an integrity of the continuous glucose sensor.
16 . The system of claim 10 , wherein the second mode comprises providing a constant basal rate of insulin.
17 . The system of claim 10 , wherein the instructions further cause performance of prompting the patient to recalibrate a glucose sensor that provides the sensor-generated values.
18 . The method of claim 1 , wherein reverting operation of the infusion device to the first mode comprises utilizing the blood glucose reading to calculate insulin dosages while operating in an automatic delivery mode.
19 . A method, comprising:
determining that sensor-generated values indicative of a glucose level of a patient are or are to be inhibited from use when in an automatic insulin delivery mode based on a sensor-quality metric associated with the sensor-generated values;
responsive to determining that the sensor-generated values are or are to be inhibited, switching operation of an infusion device from the automatic insulin delivery mode to a second mode;
obtaining a blood glucose reading from the patient; and
responsive to obtaining the blood glucose reading, reverting operation of the infusion device to the automatic insulin delivery mode.
20 . The method of claim 19 , wherein the automatic insulin delivery mode comprises calculation of bolus dosages of insulin based on the sensor-generated values.